• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种放射性胶体用于内乳淋巴闪烁显像的临床比较

Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.

作者信息

Kaplan W D, Piez C W, Gelman R S, Laffin S M, Rosenbaum E M, Jennings C A, McCormick C A, Harris J R, Henderson I C, Atkins H L

出版信息

J Nucl Med. 1985 Dec;26(12):1382-5.

PMID:4067640
Abstract

Recent studies suggest that 99mTc-labeled radiocolloid (SC) compounded with hydrogen sulfide can be used to visualize lymph channels and nodes. Our study prospectively compared SC with 99mTc antimony sulfide (SbS) colloid, in 28 patients undergoing internal mammary lymphoscintigraphy. Images were recorded on a scintillation camera and computer at 0.5, 1.0, and 3.0 hr. Quantitative analysis included assessment of percent (%) injected dose in nodes, the percent remaining at the injection site, and the relative intensity of the most cephalad node compared to a 57Co standard. The mean (means) % injected dose of both radiocolloids within visualized nodes was less than 1% at each time interval, with no significant differences between means's. The means % injected dose remaining at the injection site at 3.0 hr was 83 for SbS and 76 for SC not statistically significant (N.S.). The means of the ratio of counts within the most cephalad node at 3.0 hr to counts within a 57Co standard was 0.98 for SbS and 1.03 for SC (N.S.). Clinical assessment of number of nodes visualized and extent of radiocolloid migration showed no difference between the two agents. The biological and clinical parameters for the two colloids appear similar when used for internal mammary lymphoscintigraphy.

摘要

近期研究表明,与硫化氢复合的99mTc标记放射性胶体(SC)可用于淋巴管和淋巴结显影。我们的研究前瞻性地比较了SC与99mTc硫化锑(SbS)胶体在28例接受内乳淋巴闪烁显像的患者中的应用情况。在0.5、1.0和3.0小时用闪烁相机和计算机记录图像。定量分析包括评估淋巴结中注入剂量的百分比(%)、注射部位剩余的百分比以及最头侧淋巴结与57Co标准相比的相对强度。在每个时间间隔,两种放射性胶体在显影淋巴结内的平均(均值)注入剂量百分比均小于1%,均值之间无显著差异。3.0小时时,SbS在注射部位剩余的注入剂量均值百分比为83,SC为76,无统计学意义(N.S.)。3.0小时时,最头侧淋巴结内计数与57Co标准内计数之比的均值,SbS为0.98,SC为1.03(N.S.)。对显影淋巴结数量和放射性胶体迁移范围的临床评估显示,两种制剂之间无差异。用于内乳淋巴闪烁显像时这两种胶体的生物学和临床参数似乎相似。

相似文献

1
Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.两种放射性胶体用于内乳淋巴闪烁显像的临床比较
J Nucl Med. 1985 Dec;26(12):1382-5.
2
A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication.用于淋巴闪烁造影的两种锝-99m标记放射性药物的比较:简要通信
J Nucl Med. 1979 Sep;20(9):933-7.
3
Mammary lymphoscintigraphy in breast cancer.乳腺癌的乳腺淋巴闪烁造影术。
J Nucl Med. 1995 Oct;36(10):1775-80.
4
Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy.
J Nucl Med. 1995 Oct;36(10):1895-901.
5
Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid.99m锝硫化锑胶体淋巴闪烁显像术中的剂量测定
J Nucl Med. 1982 Aug;23(8):698-705.
6
Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
J Nucl Med. 1986 Jul;27(7):1116-24.
7
Lymphoscintigraphy in staging and management of breast cancer.
Bangladesh Med Res Counc Bull. 2000 Apr;26(1):8-14.
8
Lymphoscintigraphy in the staging of solid tumors.实体瘤分期中的淋巴闪烁显像术。
Surg Gynecol Obstet. 1983 Mar;156(3):384-91.
9
Ultrasonic guidance for internal mammary lymphoscintigraphy.内乳淋巴闪烁造影的超声引导
J Nucl Med. 1988 Oct;29(10):1744-5.
10
Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits.定量淋巴闪烁造影术I:家兔胸骨旁淋巴结中放射性胶体最佳摄取的基本概念
J Nucl Med. 1979 Oct;20(10):1038-46.

引用本文的文献

1
Comparison between preoperative and intraoperative injection of (99m)Tc Dextran-500 for sentinel lymph node localization in breast cancer.术前与术中注射(99m)锝标记右旋糖酐-500用于乳腺癌前哨淋巴结定位的比较
Am J Nucl Med Mol Imaging. 2014 Sep 6;4(6):602-10. eCollection 2014.
2
The infiltrated radiopharmaceutical injection: dosimetric considerations.放射性药物浸润注射:剂量学考量
Eur J Nucl Med. 1988;14(2):93-7. doi: 10.1007/BF00253448.